The Centers for Medicare & Medicaid Services (CMS) recently released guidelines to ensure that states have the necessary tools to properly address a nationwide epidemic—the opioid crisis.
The guidelines include information on resources available to states and the different approaches available to combat the crisis; it also outlines practices to help states meet the needs of beneficiaries dealing with an opioid addiction.
Guidance also focuses on services for infants with Neonatal Abstinence Syndrome (NAS) a postnatal drug withdrawal that is prevalent among infants exposed to opioids shortly after birth, according to a CMS press release. Advising states on how to maximize benefits of federal funding to enhance Medicaid technology is another priority to effectively battle the addiction crisis.
In the agency’s press release, Health and Human Services (HHS) Secretary Alex Azar said,
The number of American infants born dependent on opioids each day is heartbreaking. Today’s announcement reflects the Trump Administration and HHS’s commitment to helping states use Medicaid to support treatment for this condition and other challenges produced by our country’s crisis of opioid addiction. State-level innovation, including in the use of prescription drug monitoring programs and electronic health records, has been and will be a key piece of ending this crisis.
The National Institute of Drug Abuse reported that in 2012, one in every 25 infants was born with NAS—a five-fold increase from 2000. These new strategies aim to improve opioid safety within Medicaid plans.
Click here to read the letter issued to state Medicaid directors from CMS.
To read The Hill’s article on the new guidances, click here.
Read the press release issued by CMS.